{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"BioTech Nation ... with Dr. Moira Gunn","title":"No More Transfusions!!! Dr. John Scarlett, President and CEO of Geron Corporation","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/15fd8fae\"></iframe>","width":"100%","height":180,"duration":930,"description":"Dr. John Scarlett, President and CEO of Geron Corporation talks about their drug Imetelstat for myelodysplastic syndrome (MDS). MDS patients often require frequent blood transfusions, impacting their quality of life. Imetelstat, a telomerase inhibitor, aims to reduce transfusion dependence by targeting cancer cells in the bone marrow. Phase three trials showed promising results, with 40% of patients experiencing at least an 8-week transfusion-free interval. ","thumbnail_url":"https://img.transistorcdn.com/2O-bvNE3apnAmlMA6TtfHcDLDnv2fCS4nzWuofCE46M/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzMxMTgyLzE2NTM3/NjI1NzctYXJ0d29y/ay5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}